{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:22:09Z","timestamp":1782181329813,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00115-018-0609-y","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T03:55:53Z","timestamp":1537847753000},"page":"1143-1153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Kryptogener Schlaganfall und offenes Foramen ovale","Cryptogenic stroke and patent foramen ovale"],"prefix":"10.1007","volume":"89","author":[{"name":"die Deutsche Gesellschaft f\u00fcr Neurologie (DGN)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Christoph","family":"Diener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"die Deutsche Schlaganfall-Gesellschaft (DSG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"die Deutsche Gesellschaft f\u00fcr Kardiologie\u2011, Herz- und Kreislaufforschung (DGK)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"die Schweizerische Neurologische Gesellschaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin J.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Baldus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Gr\u00f6schel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Liebetrau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Massberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"M\u00f6llmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Nef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Weimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"W\u00f6hrle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Mattle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"issue":"4","key":"609_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","volume":"13","author":"RG Hart","year":"2014","unstructured":"Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O\u2019Donnell MJ et\u00a0al (2014) Embolic strokes of undetermined source: the case for a\u00a0new clinical construct. Lancet Neurol 13(4):429\u2013438","journal-title":"Lancet Neurol"},{"key":"609_CR2","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"H Diener","year":"2012","unstructured":"Diener H, Weimar C, Berlit P, Deuschl G, Elger C, Gold R et\u00a0al (2012) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie, 5.\u00a0Aufl. Thieme, Stuttgart","edition":"5"},{"issue":"18","key":"609_CR3","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","volume":"318","author":"P Lechat","year":"1988","unstructured":"Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M et\u00a0al (1988) Prevalence of patent foramen ovale in patients with stroke. N\u00a0Engl J Med 318(18):1148\u20131152","journal-title":"N Engl J Med"},{"issue":"11","key":"609_CR4","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1161\/STROKEAHA.114.007109","volume":"45","author":"AH Katsanos","year":"2014","unstructured":"Katsanos AH, Spence JD, Bogiatzi C, Parissis J, Giannopoulos S, Frogoudaki A et al (2014) Recurrent stroke and patent foramen ovale: a\u00a0systematic review and meta-analysis. Stroke 45(11):3352\u20133359","journal-title":"Stroke"},{"issue":"11","key":"609_CR5","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1009639","volume":"366","author":"AJ Furlan","year":"2012","unstructured":"Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW et\u00a0al (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N\u00a0Engl J Med 366(11):991\u2013999","journal-title":"N Engl J Med"},{"issue":"12","key":"609_CR6","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","volume":"368","author":"B Meier","year":"2013","unstructured":"Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D et al (2013) Percutaneous closure of patent foramen ovale in cryptogenic embolism. N\u00a0Engl J Med 368(12):1083\u20131091","journal-title":"N Engl J Med"},{"issue":"12","key":"609_CR7","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","volume":"368","author":"JD Carroll","year":"2013","unstructured":"Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA et\u00a0al (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N\u00a0Engl J Med 368(12):1092\u20131100","journal-title":"N Engl J Med"},{"issue":"11","key":"609_CR8","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","volume":"377","author":"JL Mas","year":"2017","unstructured":"Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L et\u00a0al (2017) Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N\u00a0Engl J Med 377(11):1011\u20131021","journal-title":"N Engl J Med"},{"issue":"11","key":"609_CR9","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L Sondergaard","year":"2017","unstructured":"Sondergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE et al (2017) Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N\u00a0Engl J Med 377(11):1033\u20131042","journal-title":"N Engl J Med"},{"issue":"11","key":"609_CR10","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","volume":"377","author":"JL Saver","year":"2017","unstructured":"Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS et al (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N\u00a0Engl J Med 377(11):1022\u20131032","journal-title":"N Engl J Med"},{"issue":"20","key":"609_CR11","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","volume":"71","author":"PH Lee","year":"2018","unstructured":"Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH et al (2018) Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J\u00a0Am Coll Cardiol 71(20):2335\u20132342","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"609_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1161\/STROKEAHA.117.020030","volume":"49","author":"G Ntaios","year":"2018","unstructured":"Ntaios G, Papavasileiou V, Sagris D, Makaritsis K, Vemmos K, Steiner T et al (2018) Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient Ischemic attack: updated systematic review and meta-analysis. Stroke 49(2):412\u2013418","journal-title":"Stroke"},{"issue":"3","key":"609_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s00415-018-8750-x","volume":"265","author":"E Abo-Salem","year":"2018","unstructured":"Abo-Salem E, Chaitman B, Helmy T, Boakye EA, Alkhawam H, Lim M (2018) Patent foramen ovale closure versus medical therapy in cases with cryptogenic stroke, meta-analysis of randomized controlled trials. J\u00a0Neurol 265(3):578\u2013585","journal-title":"J Neurol"},{"issue":"5","key":"609_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.7326\/M17-3033","volume":"168","author":"S Rosa De","year":"2018","unstructured":"De Rosa S, Sievert H, Sabatino J, Polimeni A, Sorrentino S, Indolfi C (2018) Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale: a systematic review and meta-analysis. Ann Intern Med 168(5):343\u2013350","journal-title":"Ann Intern Med"},{"issue":"5","key":"609_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.7326\/M17-2679","volume":"168","author":"R Shah","year":"2018","unstructured":"Shah R, Nayyar M, Jovin IS, Rashid A, Bondy BR, Fan TM et al (2018) Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta-analysis. Ann Intern Med 168(5):335\u2013342","journal-title":"Ann Intern Med"},{"issue":"18","key":"609_CR16","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1093\/eurheartj\/ehy121","volume":"39","author":"Y Ahmad","year":"2018","unstructured":"Ahmad Y, Howard JP, Arnold A, Shin MS, Cook C, Petraco R et al (2018) Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a\u00a0meta-analysis of randomized controlled trials. Eur Heart\u00a0J 39(18):1638\u20131649","journal-title":"Eur Heart J"},{"issue":"7","key":"609_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","volume":"81","author":"DM Kent","year":"2013","unstructured":"Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S et al (2013) An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 81(7):619\u2013625","journal-title":"Neurology"},{"issue":"8","key":"609_CR18","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","volume":"67","author":"DM Kent","year":"2016","unstructured":"Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD et\u00a0al (2016) Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials. J\u00a0Am Coll Cardiol 67(8):907\u2013917","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"609_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/eurheartj\/ehu292","volume":"36","author":"S Stortecky","year":"2015","unstructured":"Stortecky S, da Costa BR, Mattle HP, Carroll J, Hornung M, Sievert H et al (2015) Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a\u00a0network meta-analysis. Eur Heart\u00a0J 36(2):120\u2013128","journal-title":"Eur Heart J"},{"issue":"43","key":"609_CR20","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1093\/eurheartj\/eht283","volume":"34","author":"M Hornung","year":"2013","unstructured":"Hornung M, Bertog SC, Franke J, Id D, Taaffe M, Wunderlich N et al (2013) Long-term results of a\u00a0randomized trial comparing three different devices for percutaneous closure of a\u00a0patent foramen ovale. Eur Heart\u00a0J 34(43):3362\u20133369","journal-title":"Eur Heart J"},{"issue":"12","key":"609_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12471-017-1063-3","volume":"26","author":"RJR Snijder","year":"2018","unstructured":"Snijder RJR, Suttorp MJ, Ten Berg JM, Post MC (2018) Percutaneous closure of a\u00a0patent foramen ovale after cryptogenic stroke. Neth Heart\u00a0J 26(12):5\u201312","journal-title":"Neth Heart J"},{"issue":"6","key":"609_CR22","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/STROKEAHA.117.018153","volume":"49","author":"J Saver","year":"2018","unstructured":"Saver J, Mattle H, Thaler DE (2018) Patent foramen ovale closure versus medical therapy for cryptogenic ischemic stroke: a\u00a0topical review. Stroke 49(6):1541\u20131548","journal-title":"Stroke"},{"issue":"7","key":"609_CR23","doi-asserted-by":"publisher","first-page":"e023761","DOI":"10.1136\/bmjopen-2018-023761","volume":"8","author":"H Mir","year":"2018","unstructured":"Mir H, Siemieniuk RAC, Ge LC, Foroutan F, Fralick M, Syed T et al (2018) Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a\u00a0systematic review and network meta-analysis incorporating complementary external evidence. BMJ Open 8(7):e23761","journal-title":"BMJ Open"},{"key":"609_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2018.02.023","author":"TKM Wang","year":"2018","unstructured":"Wang TKM, Wang MTM, Ruygrok P (2018) Patent foramen ovale closure versus medical therapy for cryptogenic stroke: meta-analysis of randomised trials. Heart Lung Circ. \n                    https:\/\/doi.org\/10.1016\/j.hlc.2018.02.023","journal-title":"Heart Lung Circ"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-018-0609-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0609-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0609-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T03:39:03Z","timestamp":1569382743000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-018-0609-y"}},"subtitle":["S2e-Leitlinie","S2e guidelines"],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.1007\/s00115-018-0609-y","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"assertion":[{"value":"25 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.-C.\u00a0Diener, A.J.\u00a0Grau, S.\u00a0Baldus, A.\u00a0Ghanem, K.\u00a0Gr\u00f6schel, C.\u00a0Liebetrau, S.\u00a0Massberg, H.\u00a0M\u00f6llmann, H.\u00a0Nef, D.\u00a0Sander, C.\u00a0Weimar, J.\u00a0W\u00f6hrle und H.\u00a0Mattle haben ihre Interessenerkl\u00e4rungen (AWMF-Formular zur Erkl\u00e4rung von Interessen im Rahmen von Leitlinienvorhaben) rechtzeitig und vollst\u00e4ndig ausgef\u00fcllt beim Koordinator bzw. beim Editorial Office Leitlinien der DGN eingereicht. Die Angaben zum Interessenskonflikt aller Leitlinienautoren sind unter  einsehbar.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}